New Republic Capital’s Thermo Fisher Scientific TMO Stock Holding History

New Republic Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$615K	Sell	1,250 -808	-39%	-$439K	0.21%	87
2025 Q4	$1.19M	Buy	2,058 +1,166	+131%	+$659K	0.32%	63
2025 Q3	$433K	Buy	892 +162	+22%	+$75.4K	0.13%	102
2025 Q2	$296K	Sell	730 -110	-13%	-$46K	0.1%	133
2025 Q1	$418K	Buy	840 +13	+2%	+$7.04K	0.18%	91
2024 Q4	$431K	Sell	827 -119	-13%	-$65.4K	0.28%	85
2024 Q3	$586K	Sell	946 -172	-15%	-$102K	0.34%	64
2024 Q2	$619K	Buy	1,118 +163	+17%	+$93.4K	0.31%	64
2024 Q1	$555K	Buy	955 +126	+15%	+$70.7K	0.35%	69
2023 Q4	$440K	Buy	829 +143	+21%	+$69.2K	0.31%	79
2023 Q3	$347K	Sell	686 -62	-8%	-$33K	0.28%	78
2023 Q2	$390K	Buy	748 +28	+4%	+$15.1K	0.27%	75
2023 Q1	$415K	Buy	720 +94	+15%	+$53K	0.31%	63
2022 Q4	$345K	Buy	+626	New	+$332K	0.27%	67

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

New Republic Capital's TMO Position: Q1 2026 in Review

New Republic Capital reduced its Thermo Fisher Scientific (TMO) stake by 39% in Q1 2026, selling an estimated $439K and leaving 1,250 shares worth $615K. The position accounts for 0.21% of the portfolio, ranked #87.

New Republic Capital first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.19M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

New Republic Capital held 1,250 shares of Thermo Fisher Scientific worth $615K as of Q1 2026.
New Republic Capital sold 808 Thermo Fisher Scientific shares in Q1 2026, an estimated $439K.
Thermo Fisher Scientific made up 0.21% of New Republic Capital's portfolio in Q1 2026, its #87 holding.
New Republic Capital first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
New Republic Capital's Thermo Fisher Scientific position peaked at $1.19M in Q4 2025.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on New Republic Capital's 13F filing for Q1 2026, filed 1 May 2026.